Company Overview of Universitas Indonesia
University of Indonesia is an educational institution.
Key Executives for Universitas Indonesia
Universitas Indonesia does not have any Key Executives recorded.
Universitas Indonesia Key Developments
Merck Collaborates with University of Indonesia and Maharashtra University to Build Diabetes and Thyroid Dysfunction Healthcare Capacity in Asia
Feb 23 15
Merck introduced European Accredited Clinical Diabetes management for more than 5,000 medical and pharmacy students of both universities as part of Merck Capacity Advancement Program (CAP) in Asia. The 5 years program has been developed by EXCEMED - Excellence in Medical Education and is accredited by the European Accreditation Council of Continuous Medical Education (EACCME). The course will be taught by European and local Diabetes and Thyroid experts. Based on its long experience in diabetes management, which began in 1957 with the development of metformin, Merck seeks to raise awareness of diabetes by supporting the healthcare system to prevent, diagnose and manage the condition effectively. As part of the Merck Capacity Advancement Program, by end of 2015, more than 5,000 medical students in partnership with African universities such as University of Nairobi, Makerere University, Namibia University and University of Ghana, in addition to Asian universities such as Maharashtra university, India and University of Indonesia will benefit from European-accredited clinical diabetes and chronic diseases management training, which is seeking to equip them with skills to avert the diabetes epidemic. Merck is planning to target more than 15,000 students by the end of 2018 expanding to more Universities in the developing countries.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries